NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
2.060
+0.090 (4.57%)
At close: Apr 13, 2026, 4:00 PM EDT
2.063
+0.003 (0.16%)
Pre-market: Apr 14, 2026, 4:08 AM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $8.57 million as of April 13, 2026. Its market cap has increased by 40.55% in one year.
Market Cap
8.57M
Enterprise Value
-23.16M
1-Year Change
40.55%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $8.57M, a decrease of -98.33%. That is a compound annual growth rate of -38.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 8.60M | -42.67% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 9.28M |
| Lunai Bioworks | 8.97M |
| Liminatus Pharma | 8.41M |
| Evogene | 8.30M |
| Creative Medical Technology Holdings | 7.91M |
| Quince Therapeutics | 7.59M |
| TransCode Therapeutics | 7.53M |
| Acurx Pharmaceuticals | 7.45M |